Associate Director, Clinical Supply Chain Planning
Revolution Medicines
Summary
Collaborating with product leads and study managers, will ensure global clinical demand for RevMed and Non Rev-Med commercial products is accurately reflected within the N-side system on a monthly basis as part of DnOP process. Drive business process standardization, implementation, and training on new processes.
Job description
The Opportunity
Collaborating with product leads and study managers, will ensure global clinical demand for RevMed and Non Rev-Med commercial products is accurately reflected within the N-side system on a monthly basis as part of DnOP process. Drive business process standardization, implementation, and training on new processes.
- Lead end-to-end clinical supply planning for assigned clinical programs and studies, from study start-up through closeout.
- Support the development of global clinical supply strategies aligned with clinical protocols, enrollment assumptions, dosing regimens, country activation plans, and program timelines.
- Build and maintain clinical supply forecasts, translating clinical demand into manufacturing, packaging, labeling, distribution, and inventory requirements.
- Develop scenario analyses and supply models to evaluate enrollment changes, dose modifications, cohort expansions, geographic changes, and other protocol or operational assumptions.
- Establish appropriate inventory and safety-stock strategies to maintain continuity of supply while minimizing waste, obsolescence, and expiry risk.
- Monitor inventory levels, consumption, enrollment trends, expiry dates, and other supply indicators and proactively identify potential shortages or excess inventory.
- Drive continuous improvement of clinical supply planning processes, systems, metrics, and ways of working.
- Contribute to performance management, budgeting, and long-range clinical supply planning.
- Provide guidance and subject-matter expertise to colleagues and cross-functional partners on clinical supply planning and execution.
Required Skills, Experience and Education
- Bachelor’s degree in Supply Chain, Life Sciences, Engineering, Business, or a related discipline; advanced degree preferred.
- Typically 8+ years of relevant experience in pharmaceutical or biotechnology supply chain, including substantial experience supporting clinical-stage programs.
- Demonstrated experience independently managing clinical supply planning for complex, global clinical studies.
- Oncology experience preferred.
- Strong understanding of clinical development and the clinical supply lifecycle, including forecasting, manufacturing planning, packaging and labeling, distribution, depot management, inventory management, and returns/reconciliation.
- Experience developing demand forecasts and scenario models based on enrollment, dosing, treatment duration, randomization, site activation, and other clinical assumptions.
- N-side forecasting tool experience.
- Working knowledge of IRT/RTSM systems and their role in clinical supply management.
- Understanding of GMP/GDP requirements and relevant regulatory expectations governing clinical trial materials.
- Demonstrated ability to identify supply risks, evaluate tradeoffs, and develop practical mitigation strategies in a dynamic clinical development environment.
- Strong analytical, organizational, and problem-solving skills with attention to detail and the ability to manage multiple studies and competing priorities.
- Excellent communication and stakeholder-management skills, with demonstrated ability to influence cross-functional teams without direct authority.
- Ability to operate effectively in a fast-paced, evolving environment where study assumptions and priorities may change rapidly.
Preferred Skills
- Experience supporting multiple clinical programs or studies simultaneously across different phases of development.
- Experience with oncology or other complex clinical development programs.
- Experience with global clinical trials and country-specific supply requirements.
- Familiarity with clinical supply planning, ERP, inventory management, and forecasting systems.
- Experience establishing clinical supply KPIs, dashboards, or operational performance metrics.
- Demonstrated experience improving clinical supply processes and implementing scalable planning practices.
Requirements
- Bachelor’s degree in Supply Chain, Life Sciences, Engineering, Business, or a related discipline
- Typically 8+ years of relevant experience in pharmaceutical or biotechnology supply chain
- Substantial experience supporting clinical-stage programs
- Demonstrated experience independently managing clinical supply planning for complex, global clinical studies
- Strong understanding of clinical development and the clinical supply lifecycle
- Experience developing demand forecasts and scenario models
- N-side forecasting tool experience
- Working knowledge of IRT/RTSM systems
- Understanding of GMP/GDP requirements
- Demonstrated ability to identify supply risks and develop mitigation strategies
- Strong analytical, organizational, and problem-solving skills
- Excellent communication and stakeholder-management skills
- Ability to operate effectively in a fast-paced, evolving environment
Benefits
- Competitive cash compensation
- Equity awards
- Health insurance
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.